Please login to the form below

Not currently logged in
Email:
Password:

Publicis Life Brands Resolute hires Simon Goldsborough

Latest recruit brings more than 10 years in-house and agency experience

Publicis Life Brands Resolute hires Simon GoldsboroughContinuing to expand its team of experienced, senior healthcare communication practitioners, Publicis Life Brands Resolute (PLBR) has hired Simon Goldsborough as account director.

Goldsborough brings over 10 years' experience across healthcare, public, voluntary and consumer sectors, working both in-house and for agencies.

Previously, Goldsborough was at Munro & Forster Communications, where he directed programmes in a variety of therapy areas, including infectious diseases and oncology.

His expertise also includes Department of Health and advocacy group public awareness campaigns – specifically national, local and specialist media relations, event management, social media activities and stakeholder engagement.

“Simon's background, experience and skills will be a great addition and complement our existing team,” said Anna Korving, managing director. “We have been focusing our recruitment efforts on finding the best and the brightest talent within the healthcare sector and this hire exemplifies that effort.”

Goldsborough has also served at PR firms Third Sector PR and Grayling, and in media relations roles at the charities 4Children and Parkinson's UK.

11th July 2013

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics